Catalytic Wealth RIA LLC Purchases New Position in The Cooper Companies, Inc. (NASDAQ:COO)

Catalytic Wealth RIA LLC purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 3rd quarter, Holdings Channel reports. The fund purchased 2,886 shares of the medical device company’s stock, valued at approximately $318,000.

Several other institutional investors have also recently made changes to their positions in COO. Ashton Thomas Securities LLC purchased a new position in Cooper Companies during the 3rd quarter valued at $25,000. Covestor Ltd lifted its position in shares of Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after purchasing an additional 200 shares during the last quarter. Portside Wealth Group LLC lifted its position in shares of Cooper Companies by 6.5% during the third quarter. Portside Wealth Group LLC now owns 10,157 shares of the medical device company’s stock worth $1,121,000 after purchasing an additional 624 shares during the last quarter. Principal Financial Group Inc. boosted its stake in shares of Cooper Companies by 6.6% during the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock valued at $26,295,000 after purchasing an additional 14,687 shares during the period. Finally, Graypoint LLC bought a new position in shares of Cooper Companies in the third quarter worth about $233,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 0.2 %

Shares of Cooper Companies stock opened at $103.55 on Tuesday. The company has a market cap of $20.62 billion, a P/E ratio of 57.69, a PEG ratio of 2.24 and a beta of 0.99. The Cooper Companies, Inc. has a 52-week low of $81.99 and a 52-week high of $112.38. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The firm’s 50 day moving average price is $107.26 and its 200-day moving average price is $97.73.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company’s revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.84 earnings per share. On average, sell-side analysts predict that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.

Insider Transactions at Cooper Companies

In other news, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at $520,488.54. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at $520,488.54. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Albert G. White III sold 114,992 shares of the stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares in the company, valued at $18,267,624.69. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 256,373 shares of company stock worth $27,637,427 over the last three months. 2.00% of the stock is currently owned by insiders.

Analyst Ratings Changes

COO has been the subject of several research reports. StockNews.com raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Friday. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Piper Sandler raised their price objective on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Robert W. Baird lifted their target price on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. Finally, Morgan Stanley increased their price target on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Tuesday, September 10th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.